, /PRNewswire/ -- According to the latest BCC Research study, the demand for should reach by 2027, with a compound annual growth rate (CAGR) of 4.2%. This report covers the latest progress in chemical compounds and the latest drugs, except those aimed at control of the vector or symptomatic treatment.
It emphasizes antibiotics, tests their market potential, segmentation of competition landscapes and markets based on the type of product (such as cell wall inhibitors, protein inhibitors, DNA, and other inhibitors), administrative pathways (oral and topical), and geographical regions (including , , , , and the and ). The analysis covers key countries in these regions and provides insight into market dynamics, pricing, the impact of COVID-19, and the regulatory environment. Market forecasts till 2027 and market share assessment of key players deepen the report and provide pharmaceutical industry stakeholders with a comprehensive view.
Antibiotic resistance is a growing problem worldwide, causing over 1.27 million deaths annually and costing the U.S.
each year. From 2000 to 2018, antibiotic use surged by 46%, especially in regions like , the , and . The COVID-19 pandemic worsened the situation, with antibiotics often misused to treat the virus.
This highlights the urgent need for better stewardship and innovative approaches to tackle antibiotic resistance globally. To learn more about "Antibiotics: Technology and Global Market Report", please for more information. The global deman.
